Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
8.42
+0.12 (1.45%)
Jul 3, 2025, 1:00 PM - Market closed
Xencor Market Cap
Xencor has a market cap or net worth of $599.26 million as of July 3, 2025. Its market cap has decreased by -50.22% in one year.
Market Cap
599.26M
Enterprise Value
79.08M
1-Year Change
-50.22%
Ranking
Category
Stock Price
$8.42
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $599.26M, an increase of 144.20%. That is a compound annual growth rate of 8.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 599.30M | -62.73% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.03B |
| Johnson & Johnson | 374.05B |
| AbbVie | 337.03B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 281.00B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 219.33B |